|
Here are some of the confirmed program areas
for COP 2001:
ANATOMIC PATHOLOGY
MEDICAL MICROBIOLOGY
HAEMATOLOGY
IMMUNOLOGY
FORENSIC PATHOLOGY
CHEMICAL PATHOLOGY
ANATOMIC PATHOLOGY
·
Dermatopathology symposium ( David Weedon,
Australia )
·
The histopathologist’s role in the recognition
of oral premalignancy (Peter
Morgan, U.K. )
·
Diagnostic problems in tumors and cysts and the
jaw (Peter Morgan, U.K.
)
·
Mastering the diagnosis and classification of
thymic epithelial tumors using the new W.H.O. classification
in 90 minutes, illustrated with slide seminar cases (John Chan, Hong Kong )
·
Workshop: Practical problems and solutions in diagnosis
of thyroid tumors ( John Chan, Hong Kong)
·
Slide Workshop on the theme “Iatrogenic lesions” (Cases
to be submitted by participants, and first 70 contributors will receive
a set of slides free of charge)
·
Breast fine needle aspiration cytology (K. Lindholm,
Sweden)
·
Genetics, Ethics and Ewe (F.Silva, USA)
.
IgA nephropathy/Berger's disease (F.Silva, USA)
.
Workshop on medical renal disease, covering approach to
classification and interpretation of renal biopsies, and
discussion of illustrative cases (F.Silva, USA)
·
Exploration of the genome with Genechip Technology (L.McAllister,
USA)
Click here to return to the top of the page
·
Resistance detection (M.
Stuelens, Belgium )
·
Monitoring gonococcal antibiotic resistance in
the region (J. Tapsall, Australia )
·
Antibiotic policies (C.
Kumana, Hong Kong )
·
Handwashing: is it necessary? (W.H.
Seto, Hong Kong )
·
The future of the clinical microbiologist (B.I.
Buerden, U.K. )
·
Applications of molecular methods in medical microbiology
(M. Peiris, Hong Kong )
·
Continuous quality improvement in clinical microbiology
(W.H. Seto, Hong Kong )
·
Molecular typing (M.
Stuelens, Belgium )
·
Fungal infection in immunocompromised patients
(K.Y. Yuen, Hong Kong
)
·
Partnership between clinical and public health
laboratories (B.I. Buerden, U.K. )
·
Emerging infections: role of the clinical laboratory
(W. Lim, Hong Kong )
·
Outbreaks and cases (D.
Tsang, Hong Kong )
·
The latest in NCCLS antibiotic susceptibility
testing (J. Jorgensen, U.S.A. )
·
Antibiotic susceptibility testing and clinical
laboratories (J. Jorgensen, U.S.A. )
·
Infection control and Quality Assurance (R. M. Whitby, Australia )
·
The Maryland Quality Indicator Project: the Singapore
Experience (M.L.
Ling, Singapore )
·
Surveillance of infection in Hospital (D.
Lyon, Hong Kong )
·
Latest technologies in infection control (P.
Ching, Hong Kong )
Click here to return to the top of the page
·
Molecular biology and hematology
.
Minimal residual disease (Alex Morley )
.
Human genome project – Impact on hematology (Ron
Trent )
.
Telomeres (P.M.
Lansdorp, Canada )
·
Red cell disorders and coagulation disorders
.
Congenital hemolytic anemia (Professor Gordon-Smith )
.
Laboratory testing for thrombophilia (B.
Chong )
.
Beta globin gene regulation and thalassemia (Phoebe
Ho)
·
Advances in malignant hematology
.
Advances in myeloma (D.E. Joshua )
.
Hypereosinophilic syndrome (S.H. Lee )
Click here to return to the top of the page
·
Autoimmune diseases and SLE
.
Clinical use of anti-nuclear antibodies (T.
Fleisher, NIH, U.S.A. )
.
Autoimmune response in SLE (K.N. Lai, Hong Kong )
.
ANCA (S.S.
Lee, Hong Kong )
.
Autoantibodies in SLE (E. Chan, Hong Kong )
·
Immunology of infectious diseases
.
HIV infection ( A. Carr, Australia; S.S.
Lee, Hong Kong)
.
EBV infection (M.H. Ng,
Hong Kong)
·
Clinical Immunology training (President
of RCPA, President of HKCPath,, Chief Examiner of RCPA, Chief
Examiner of HKCPath )
Click here to return to the top of the page
·
Pathological investigation of drug-related deaths
– meeting the challenges of new street drugs (Steven
B. Karch, U.S.A.)
·
The Human Genome Project and the future of
pharmacogenetics (Daniel W. Nebert, USA )
·
Genome-wide detection of chromosomal imbalance in mouse
and human tumours using BAC microarray (W.W. Cai, USA )
Click here to return to the top of the page
|
